Substituted isoxazole compounds
US8354398B2 · kind B2 · utility
13Cited by
3References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 22, 2010 |
| Grant date | Jan 15, 2013 |
| Priority date | — |
| Expiry date | Jan 22, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds of Formula (I)or pharmaceutically acceptable salts thereof, wherein Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.